Items Tagged ‘Dr. John Copland’
June 3, 2016
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor: Emily Blahnik NBC News Too Fat to Fight: Is the Obesity Crisis […]
Tags: 3D technology, ABC News, Albert Lea Tribune, alzheimer's disease, alzheimers, Becker's Hospital News, biobank, biopsy, Canada, cancer drugs, Cancer.net, Carlsen twins
October 29, 2015
Mayo Clinic In the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Laura Wuotila with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Editor, Karl Oestreich; Assistant Editor: Carmen Zwicker Wall Street Journal Scientists Probe Indoor Work Spaces for Clues to […]
Tags: "habit cough" (HC), "non-activity thermogenesis, A.L.S., AARP, Abnormal Thyroid Function, Advance Directives Task Force, Alzheimer's Caregivers, Alzheimer's disease (AD), anaplastic thyroid cancer, Apervita, Apnea Treatment Vacuum, Arizona Capital Times
July 24, 2014
Mayo Clinic in the News Weekly Highlights
Mayo Clinic in the News is a weekly highlights summary of major media coverage. If you would like to be added to the weekly distribution list, send a note to Emily Blahnik with this subject line: SUBSCRIBE to Mayo Clinic in the News. Thank you. Karl Oestreich, manager enterprise media relations Advisory Board Why Mayo Clinic’s CEO wants […]
Tags: "sitting disease", A.L.S., ABC News, ABC15, advisory board, Ahwatukee Foothills News, Aitkin Age, Albuquerque Journal, alzheimer's disease, Am.com, AP, Apple
August 2, 2012
Blood Cancer Drug Effective in Treating Kidney, Breast Cancer
Two drugs approved by the Food and Drug Administration for blood cancer treatment may also be used to treat triple negative breast and kidney cancer, researchers say. The drugs are romidepsin and decitabine. Together they can activate a gene sFRP1 (secreted frizzled related protein one) that can stop the growth of cancer cells. “We now […]
Tags: decitabine, Dr. John Copland, FDA, Medical Daily, romidepsin